Counseling the patient who has genital herpes or genital human papillomavirus infection

Infectious Disease Clinics of North America

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 459-476

  Warren, Terri ^a   Ebel, Charles ^b  

^a Westover Heights Clinic   (United States)

^b American Social Health Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; CONDYLOMA; COUNSELING; FOLLOW UP; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE SYSTEM; INFECTION RISK; LABORATORY TEST; PREGNANCY; REINFORCEMENT; REVIEW; RISK ASSESSMENT; SEXUALITY; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS SHEDDING; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

EID: 20444469674     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2005.03.011     Document Type: Review

References (76)

1. D.T. Fleming, G.M. McQuillan, and R.E. Johnson Herpes simplex virus type 2 in the United States, 1976 to 1994 N Engl J Med 337 16 1997 1105 1111
2. P. Leone, D.T. Fleming, and A.W. Gilsenan Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States Sex Transm Dis 31 5 2004 311 316
3. L.P. Gilbert, S.L. Schulz, and C. Ebel Education and counselling for genital herpes: perspectives from patients Herpes 9 3 2002 78 82
4. R. Engelberg, D. Carrell, and E. Krantz Natural history of genital herpes simplex virus type 1 infection Sex Transm Dis 30 2 2003 174 177
5. A. Wald, J. Zeh, and S. Selke Virologic characteristics of subclinical and symptomatic genital herpes infections N Engl J Med 333 1995 770 775
6. A. Wald, M. Ericsson, and E. Krantz Oral shedding of herpes simplex virus type 2 Sex Transm Infect 80 4 2004 272 276
7. J. Benedetti, J. Zeh, and L. Corey Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time Ann Intern Med 131 1 1999 14 20
8. G.J. Mertz, J. Benedetti, and R. Ashley Risk factors for the sexual transmission of genital herpes Ann Intern Med 116 3 1992 197 202
9. M. Reitano, S. Tyring, and W. Lang Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study J Infect Dis 178 3 1998 603 610
10. S.L. Sacks Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial J Infect Dis 189 8 2004 1341 1347
11. B. Romanowski, R.B. Marina, and J.N. Roberts Valtrex HS230017 Study Group. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study Sex Transm Dis 30 3 2003 226 231
12. L. Corey, A. Wald, and R. Patel Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes N Engl J Med 350 1 2004 11 20
13. ACOG Practice Bulletin Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections Obstet Gynecol 104 5 Pt 1 2004 1111 1118
14. A. Wald, A. Langenberg, and K. Link Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women JAMA 285 24 2001 3100 3106
15. C. Casper, and A. Wald Condom use and the prevention of genital herpes acquisition Herpes 9 1 2002 10 14
16. M. Brentjens, K. Yeung-Yue, and P.C. Lee Recurrent genital herpes treatments and their impact on quality of life Pharmacoeconomics 21 12 2003 853 863
17. O. Carney, E. Ross, and C. Bunker A prospective study of the psychological impact on patients with a first episode of genital herpes Genitourin Med 70 1 1994 40 45
18. O. Carney, E. Ross, and G. Ikkos The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes Genitourin Med 69 6 1993 457 459
19. S.K. Tyring, D. Baker, and W. Snowden Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir J Infect Dis 186 Suppl 1 2002 S40 S46
20. Z.A. Brown, A. Wald, and R.A. Morrow Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant JAMA 289 2 2003 203 209
21. B. Song, D.E. Dwyer, and A. Mindel HSV type specific serology in sexual health clinics: use, benefits, and who gets tested Sex Transm Infect 80 2 2004 113 117
22. R.L. Ashley Sorting out the new HSV type specific antibody tests Sex Transm Infect 77 4 2001 232 237
23. G. Sucato, A. Wald, and E. Wakabayashi Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region J Infect Dis 177 4 1998 1069 1072
24. Z. Brown, S. Selke, and J. Zeh The acquisition of herpes simplex virus during pregnancy N Engl J Med 337 8 1997 509 515
25. C.M. Roberts, J.R. Pfister, and S.J. Spear Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students Sex Transm Dis 30 10 2003 797 800
26. W.E. Lafferty, L. Downey, and C. Celum Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention J Infect Dis 181 4 2000 1454 1457
27. L. da Silva, A. Guimaraes, and J. Victoria Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients Oral Dis 11 1 2005 13 16
28. S. Blower, and L. Ma Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications Clin Infect Dis 39 Suppl 5 2004 S240 S247
29. E. Freedman, and A. Mindel Epidemiology of herpes and HIV co-infection J HIV Ther 9 1 2004 4 8
30. C. Celum, R. Levine, and M. Weaver Genital herpes and human immunodeficiency virus: double trouble Bull World Health Organ 82 6 2004 447 453
31. C.L. Celum, N.J. Robinson, and M.S. Cohen Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection J Infect Dis 191 Suppl 1 2005 S107 S114
32. L. Corey, A. Wald, and C.L. Celum The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics J Acquir Immune Defic Syndr 35 5 2004 435 445
33. D. Watts, Z. Brown, and D. Money A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery Am J Obstet Gynecol 188 3 2003 836 843
34. J. Melville, S. Sniffen, and R. Crosby Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment Sex Transm Infect 79 4 2003 280 285
35. C. Diamond, S. Selke, and R. Ashley Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease Sex Transm Dis 26 4 1999 221 225
36. S.L. Dibble, and J.M. Swanson Gender differences for the predictors of depression in young adults with genital herpes Public Health Nurs 17 3 2000 187 194
37. J.L. Levenson, R.M. Hamer, and T. Myers Psychological factors predict symptoms of severe recurrent genital herpes infection Psychosom Res 31 2 1987 153 159
38. M. Rein Stress and genital herpes recurrences in women JAMA 283 11 2000 1394
39. K.H. Rand, E.F. Hoon, and J.K. Massey Daily stress and recurrence of genital herpes simplex Arch Intern Med 150 9 1990 1889 1893
40. E.F. Hoon, P.W. Hoon, and K.H. Rand A psycho-behavioral model of genital herpes recurrence Psychosom Res 35 1 1991 25 36
41. A. Nack Damaged goods: women managing the stigma of STDs Deviant Behav 21 2 2000 95 121
42. A.G. Langenberg, L. Corey, and R.L. Ashley A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group N Engl J Med 341 19 1999 1432 1438
43. A. Wald, J. Zeh, and S. Selke Reactivation of genital herpes simplex virus type 2 infections in asymptomatic seropositive persons N Engl J Med 342 12 2000 844 850
44. S. Sacks, P. Griffiths, and L. Corey HSV shedding Antiviral Res 63 Suppl 1 2004 S19 S26
45. A. Wald, M. Huang, and D. Carrell Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture J Infect Dis 188 9 2003 1345 1351
46. R. Gupta, A. Wald, and E. Krantz Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract J Infect Dis 190 8 2004 1374 1381
47. A. Wald, L. Corey, and R. Cone Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment J Clin Invest 99 5 1997 1092 1095
48. H. Weinstock, S. Berman, and W. Cates Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000 Perspect Sex Reprod Health 36 1 2004 6 10
49. L. Koutsky Epidemiology of genital human papillomavirus infection Am J Med 102 5A 1997 3 8
50. D. Jenkins, C. Sherlaw-Johnson, and S. Gallivan Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 65 6 1996 763 773
51. T.C. Wright Jr., M. Schiffman, and D. Solomon Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2 2004 304 309
52. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2003 2003 U.S. Department of Health and Human Services Atlanta (GA)
53. M.J. Campion, J.R. Brown, and D.J. McCance Psychosexual trauma of an abnormal pap smear Br J Obstet Gynaecol 95 2 1988 175 181
54. J. Waller, K.J. McCaffery, and S. Forrest Human papillomavirus and cervical cancer: issues for biobehavioral and psychosocial research Ann Behav Med 27 1 2004 68 79
55. P. Clarke, C. Ebel, and D.N. Catotti The psychosocial impact of human papillomavirus infection: implications for health care providers Int J STD AIDS 7 1996 197 200
56. M. Linnehan, and N.E. Groce Psychosocial and educational services for female college students with genital human papillomavirus infection Fam Plann Perspect 31 3 1999 137 141
57. E. Maissi, T.M. Marteau, and M. Hankins Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study BMJ 328 7451 2004 1293 1299
58. M. Keller, V. von Sadovszky, and B. Pankratz Self-disclosure of HPV infection to sexual partners West J Nurs Res 22 3 2000 285 302
59. B. Monk, and D.J. Wiley Human papillomavirus infections: truth or consequences Cancer 100 2 2004 225 227
60. B. Reed, M.T. Ruffin IV, and D.W. Gorenflo The psychosexual impact of human papillomavirus cervical infections J Fam Pract 48 2 1999 110 116
61. Brandt H, Sharpe PA, Abbott JM, et al. Health care providers' interactions with women who have human papillomavirus (HPV). Presented at the 131st Annual Meeting of the American Public Health Association. San Francisco, November 15-19, 2003.
62. T.J.M. Helmerhorst, and C.J.L.M. Meijer Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD Int J Gynecol Cancer 12 2002 235 236
63. D. Harper Why am I scared of HPV? CA Cancer J Clin 54 5 2004 245 247
64. H. Baer, S. Allen, and L. Braun Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research J Community Health 25 1 2000 67 78
65. E. Yacobi, C. Tennant, and J. Ferrante University students' knowledge and awareness of HPV Prev Med 28 6 1999 535 541
66. Packing-Ebuen J, Rayko H, Wallace F, et al. Lack of HPV knowledge: what women don't know could hurt them... Presented at the 131st Annual Meeting of the American Public Health Association. San Francisco, November 15-19, 2003.
67. Naoom S, Buie ME, Daley E, et al. HPV: adolescents at risk for a potentially life threatening disease. Presented at the 131st Annual Meeting of the American Public Health Association. San Francisco, November 15-19, 2003.
68. R. Anhang, J.E. Stryker, and T.C. Wright Jr. News media coverage of human papillomavirus Cancer 100 2 2004 308 314
69. R. Anhang, T.C. Wright Jr., and L. Smock Women's desired information about human papillomavirus Cancer 100 2 2004 315 320
70. L. Gilbert, L. Alexander, and J.F. Grosshans Answering frequently asked questions about HPV Sex Transm Dis 30 3 2003 193 194
71. American Cancer Society. What women should know about HPV and cervical health. 2003. Available at: http://www.cancer.org/docroot/NWS/content/ NWS_2_1x_What_Women_Should_Know_about_HPV_and_Cervical_Health.asp. Accessed December 14, 2004.
72. American Society for Colposcopy and Cervical Pathology. What women should know about HPV and cervical health. 2004. Available at: http://www.asccp.org/ pdfs/patient_edu/women_should_know.pdf. Accessed December 2, 2004.
73. Brandt H, McCree DH, Lindley LL, et al. A formal evaluation of existing printed HPV educational materials. Presented at the 131st Annual Meeting of the American Public Health Association, San Francisco, CA, November 15-19, 2003.
74. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002 MMWR 51 No. RR-6 2002 53 59
75. National Institutes of Health Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention 2001 U.S. Department of Health and Human Services Bethesda (MD)
76. M. Reitano Counseling patients with genital warts Am J Med 102 5A 1997 38 43